News Industry News Merck Says Additional Information Provided to Investigators in Clinical Study of Vorapaxar January 18, 2011
News Daily News Different Factors Linked to Early, Late Mortality with CoreValve TAVI L.A. McKeown January 13, 2011
News Industry News Abbott Receives CE Mark Approval for World's First Drug Eluting Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease January 09, 2011